Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 08, 2022
Insilico Medicine, a clinical stage artificial intelligence driven drug discovery company, announced a multi-year, multi-target strategic research collaboration with Sanofi. Under the terms of the agreement, the collaboration will leverage Insilico ...
read more
Thursday, October 20, 2022
Farmabios, Novasep and PharmaZell officially announced that they are coming together under the new brand Axplora.
read more
Thursday, October 20, 2022
Mikart entered into a collaboration agreement with Fluid Pharma Ltd, a technology licensing company, to advance the application of Fluid Pharma's proprietary MicroCoat™ technology in new therapies for pediatric, geriatric, and oral liquid modified ...
read more
Wednesday, October 19, 2022
C2 PHARMA, a pharmaceutical group focused on manufacturing and supplying ophthalmic and niche active pharmaceutical ingredients (APIs) globally, is expanding the API product portfolio. Tropicamide API is launching with regulatory filings in both ...
read more
Tuesday, October 11, 2022
Mikart, LLC to collaborate with Nano PharmaSolutions, who has a proprietary NanoTransformer™ that enhances the solubility of pharmaceutical active ingredients (API).
read more
Tuesday, October 11, 2022
The Outsourcing Facilities Association (OFA) announced that it has reached a settlement agreement with the FDA that spurs the FDA to promptly review long-pending nominations for active pharmaceutical ingredients for use by FDA-registered outsourcing ...
read more
Thursday, October 06, 2022
Barentz International, a global life science ingredients distributor, has acquired Viachem, Ltd., a specialty distributor of life science ingredients and specialty chemicals.
read more
Thursday, September 22, 2022
Catalent, a leader in enabling biopharma, cell, gene, and consumer health partners to optimize the development, launch, and supply of better patient treatments across multiple modalities, announced that it has reached an agreement to acquire Metrics ...
read more
Wednesday, August 31, 2022
Ashland announced a strategically significant expansion of its Viatel™ bioresorbable polymer manufacturing and research and development site at the National Science Park, home to a network of innovative organizations, in Mullingar, Ireland.
read more
Thursday, August 04, 2022
Curia has appointed Niall Condon as president of its Manufacturing Division. Condon will drive growth and be responsible for operations of Curia’s commercial manufacturing services and products, including API and Drug Product.
read more
Humanigen, Inc. announced it entered into an agreement with PCI Pharma Services (PCI), a integrated global contract development manufacturing organization (CDMO), to provide importation, release and commercialization services in the United Kingdom (...
read more
Piramal Pharma Limited’s Pharma Solutions business announced that the company’s site in Digwal in the state of Telangana, India, has implemented various tools to unlock Active Pharmaceutical Ingredient (API) manufacturing capacity and support client ...
read more
Piramal Pharma Limited's Pharma Solutions business announced that a new active pharmaceutical ingredient (API) plant at the company's site in Aurora, Ontario, has come online and successfully completed its initial production runs.
read more
Catalent announced a multi-year $350 million investment at its facility in Bloomington, Indiana, to expand biologics drug substance and drug product manufacturing capabilities. The project will serve the industry’s robust biologics pipeline across ...
read more
Wednesday, April 13, 2022
Cambrex announced the completion of a $50 million expansion of its large-scale active pharmaceutical ingredient (API) manufacturing capabilities at its Charles City, Iowa facility.
read more